News sentiment analysis powered by sentiment-insight.com
November 25 - FDI Weekly Review
Medtronic (MDT +5.6%) reported better than expected quarterly revenue and earnings. Verizon (VZ +3.3%) continued its rebound that has taken the wireless telecom giant 20% higher.
Medtronic wins pulsed field ablation CE mark, teeing up 2-front challenge to Boston Scientific Medtronic received a CE mark for its single-shot pulsed field ablation (PFA) system. The CE mark covers the PulseSelect System, which Medtronic previously received for Affera. Boston Scientific’s Farapulse became the first CE marked PFA device early in 2021.
Can Medtronic plc's (NYSE:MDT) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price? Medtronic's stock is up by a considerable 8.6% over the past month. The company has seen a lack of earnings growth as a result of retaining very little profits. Medtronic has a high three-year median payout ratio of 82%.
Medtronic raises fiscal 2024 forecast on strong sales... Medtronic raises fiscal 2024 forecast on strong sales of surgical, diabetes devices. Medical device makers are seeing higher demand for their products due to a steady recovery in surgical procedures.
Medical device maker Medtronic raises fiscal 2024 profit view Medtronic on Tuesday raised its annual profit forecast for the second time this year. Lowe's posted an earnings beat in the third quarter but the stock was tumbling. Treasury investors are turning increasingly skeptical the Federal Reserve will deliver a soft landing.
Woman ended up in a coma after complaining of chest infection Sarah Mather, 28, was diagnosed with type 1 diabetes in 2010. She was suffering from severe diabetic ketoacidosis (DKA) It took her 12-18 months to fully recover from the coma. She is supporting the Medtronic #BlueBalloonCampaign.
US FDA approves Medtronic's blood pressure treatment... FDA approves Medtronic's treatment device in a surgery called renal denervation. The agency's decision is in contrast with the recommendation of a panel of independent experts.
Medical device stocks rise in relief after Wegovy heart... iShares US Medical Devices ETF rose 2.3% on Monday, eyeing its biggest one-day percentage gain since April. Shares of diabetes care device makers Abbott Laboratories, Dexcom, Insulet, Tandem and Medtronic gained between 2 and 8%.
Acutus Medical Inc (AFIB) Reports Substantial Revenue Growth in Q3 2023 Despite Negative Gross ... Acutus Medical Inc (NASDAQ:AFIB) will no longer provide financial guidance due to strategic business realignment. The company specializes in left-heart access products. Revenue increased by 44% year-over-year to $5.2 million in Q3 2023, primarily driven by the Medtronic distribution agreement.
How to invest, 3 stocks to buy now: Top-1% fund manager JPMorgan (JPM) is an exception due to its healthy deposit levels and surging net interest income. Medtronic (MDT) has taken a 13% hit in markets due to concerns about the growing popularity of weight-loss drugs.
CEOs of four global firms, Nobel laureate to address BioAsia 2024 The keynote speakers will be Dave Ricks, CEO of Eli Lilly; Chris Boerner, incoming CEO of BMS. Geoff Martha, chairman and CEO of Medtronic and Gregg Semenza, awarded the Nobel Prize in Physiology or Medicine in 2019. The theme of BioAsia will be ‘Data and AI: Redefining Possibilities’
CEOs of four global firms, Nobel laureate to address BioAsia 2024 The keynote speakers will be Dave Ricks, CEO of Eli Lilly; Chris Boerner, incoming CEO of BMS. Geoff Martha, chairman and CEO of Medtronic and Gregg Semenza, who was awarded the Nobel Prize in Physiology or Medicine in 2019 for work on oxygen sensing. The theme of BioAsia will be ‘Data and AI: Redefining Possibilities’
‘Vintage Values’: Morgan Stanley Says These Are the Top Stocks for a One-Year Buy-and-Hold Investment Horizon — Here’s What Makes Them Stand Out Medtronic has already declared its dividend for fiscal 2Q24. Payment of 69 cents per common share marks a 1-cent increase from the year-ago quarter. The company has a dividend history stretching back to the 1970s.
Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes Medtronic has an ROCE of 7.2%. In absolute terms, that's a low return and it also under-performs the Medical Equipment industry average of 9.7%. The total return to shareholders over the last five years has been flat. This probably explains why Medtronic is paying out 50% of its income to shareholders.
US FDA panel votes against use of Medtronic's blood... US FDA panel votes against use of Medtronic's blood pressure treatment device. Same panel on Tuesday voted in favor of rival ReCor's device for use in a surgery called renal denervation.
Reuters Health News Summary Medtronic joins rivals in benefiting from rise in non-urgent surgeries. The company makes pacemakers, catheters and other tools used in heart and gastrointestinal surgeries.
Medtronic raises annual forecast as demand for medical... Medtronic raises annual forecast as demand for medical procedures picks up. The Dublin-based medical device maker reported a profit of $1.20 per share for the first quarter.
How Hildegard Steenkamp stole half a billion from her employer Hildegard Steenkamp's gravy train started with the theft of R24 000 from her then employer, Medtronic, on 20 December 2004. The Johannesburg Commercial Crimes Court heard on Monday that most of the R537 million she embezzled from her employer went on gambling and a lavish lifestyle.
Q2 2023 DiaMedica Therapeutics Inc Earnings Call An audio recording of the webcast will be available shortly after the call today on DiaMedica's website at www.diamedica.com. Dr. Richard Kuntz recently retired from Medtronic, where he was the Chief Medical Officer.
Elon Musk is 'totally out of his element' at Twitter because he doesn't 'understand social media,' a Harvard leadership expert says Elon Musk bought Twitter in a $44 billion deal in October 2022. Bill George, an executive fellow at Harvard Business School and former CEO of Medtronic, thinks Musk is "totally out of his element" George suggested that Musk should let Twitter's new CEO Linda Yaccarino call the shots.
Sign Up
